LOGO
LOGO

Keep An Eye On Tarsus Pharma...

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024 lt

Eyelids play a very important role in protecting our eyes by sweeping away dirt and spreading moisture (tears) over the surface. Eyelid diseases represent one of the largest untapped opportunities in ophthalmology. Among these, blepharitis and meibomian gland dysfunction are very common, and yet, they often go underdiagnosed and underappreciated in clinical practice.

The stock we are bringing to your attention today is that of Tarsus Pharmaceuticals Inc. (TARS), a biopharmaceutical company developing therapeutic candidates for pervasive and damaging eyelid diseases.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.